The Emerging FCPA Enforcement Paradigm: Is the U.S. Department of Justice Turning Corporate Defense Lawyers into Quasi-prosecutors Against Individual Employees?
13 April 2018
Partner David W. Simon will travel to Munich, Germany, to deliver a presentation on recent developments in United States law with respect to enforcement of the Foreign Corrupt Practices Act (FCPA) and other anti-corruption laws. His presentation is part of an event entitled Internationaler Strafrechtstag: Internationale Korruption – aus Sicht der Strafverteidigung (International Criminal Law Day: International Corruption – From the Perspective of Criminal Defense), hosted by the German Defense Counsel Association and law firm Deutsche Strafverteidiger e.V. in Munich, Germany.
Topics include:
- “Globalized Economic Criminal Proceedings, International Corruption and the (Eroding) Protection of Accused Rights” (Prof. Dr. Dr. h.c. Mark Pieth, Full Professor of Criminal Law, University of Basel Law Faculty)
- The Scope of the Facts to Combat International Corruption Under German Criminal Law” (Dr. Thomas Grützner, Munich Attorney)
- “National Criminal Defense Against International Corruption Pursuit: The Battle of David Against Goliath?” (Daniel Amelung, Attorney and Specialist Lawyer for Criminal Law, Munich)
- Panel: “International Corruption and Internal Investigations” (Hildegard Bäumler-Hösl, Attorney-General Head of Department, Munich; Alexander Schemmel, Munich Attorney; and Daniel Amelung, Attorney and Specialist Lawyer for Criminal Law, Munich)
- “The European Public Prosecutor’s Office and OLAF – The New Institutional Framework for the Fight Against Fraud and Corruption at European Level” (Margarete Hofmann, Director, European Commission, European Anti-Fraud Office)
- “The Emerging FCPA Enforcement Paradigm: Is the U.S. Department of Justice Turning Corporate Defense Lawyers into Quasi-prosecutors Against Individual Employees?” (David Simon, Partner, Foley & Lardner LLP, Milwaukee, WI and Washington, D.C.)
- “Corruption and Compliance in India: Legal Defense Perspectives” (Sherbir Panag, Managing Partner, Panag & Babu, New Delhi, India)
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.